PTPRC and neoplasm: CBD–SIRPαFc significantly increased the frequency of MHC II+ M1 macrophages in CD45+F4/80+ macrophages within the tumor (Figure 6D), but the frequency of CD206+ M2 macrophages was maintained in all groups (Figure 6F).